600771.SS
600771.SS
CNE000000MY1
GUANGYUYUAN CHINESE HERBAL MEDI
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 90/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±37.8% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.3x).

Beta (Market Relation)
0.28x
Defensive
Volatility (5Y p.a.)
37.8% p.a.
5-Year Horizon
Max Drawdown (5Y)
-70.8%
5-Year Horizon
Sharpe Ratio
-0.41
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -24.5%
3 Years 32.3% -59.6% -0.75 -21.6%
5 Years 37.8% -70.8% -0.41 -12.9%
10 Years 42.7% -76.2% -0.19 -5.4%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 102.7 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -76.2% in the extended horizon.
ende